KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Gross Margin (2017 - 2026)

Cardlytics filings provide 10 years of Gross Margin readings, the most recent being 80.3% for Q1 2026.

  • Quarterly Gross Margin fell 130.0% to 80.3% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 83.72% through Mar 2026, up 203.0% year-over-year, with the annual reading at 83.08% for FY2025, 199.0% up from the prior year.
  • Gross Margin hit 80.3% in Q1 2026 for Cardlytics, down from 86.59% in the prior quarter.
  • Across five years, Gross Margin topped out at 86.59% in Q4 2025 and bottomed at 70.85% in Q2 2022.
  • Average Gross Margin over 5 years is 80.21%, with a median of 80.3% recorded in 2026.
  • The largest annual shift saw Gross Margin soared 933bps in 2023 before it crashed -171bps in 2024.
  • Cardlytics' Gross Margin stood at 79.61% in 2022, then grew by 6bps to 84.17% in 2023, then grew by 1bps to 84.67% in 2024, then increased by 2bps to 86.59% in 2025, then decreased by -7bps to 80.3% in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Gross Margin are 80.3% (Q1 2026), 86.59% (Q4 2025), and 84.88% (Q3 2025).